Publications
Selected Publications
Abedini
MR, Wang PW, Huang YF, Cao MJ, Chou CY, Shieh DB and Tsang BK. Cell Fate Regulation by Gelsolin in Human Gynecologic
Cancers. Proc. Nat. Acad. Sci. USA (2014, In Press).
Farrand
L, Byun S, Kim JY, Im-Aram A, Lee JH, LimS, Lee KW, Suh JY, Lee HJ and Tsang BK. Piceatannol enhances
cisplatin sensitivity in ovarian cancer through modulation of the p53 tumor
suppressor pathway and induction of mitochondrial fission. J. Biol. Chem. 288:
23740-23750 (2013)
Abedini
MR, Muller EJ, Brun J, Bergeron R, Gray DA, Tsang BK. Cisplatin induces p53-dependent FLICE-like inhibitory
protein ubiquitination in ovarian cancer cells. Cancer Research 68(12):
4511-4517 (2008).
Kim
JY, Xue K, Wang Q, Liu JY, Leader A, Han JY and Tsang BK. Chemerin Suppresses Ovarian Follicular Development and
Its Potential Involvement in Follicular Arrest in Rats treated Chronically with
Dihydrotestosterone. Endocrinology 154: 2912–2923 (2013).
Wang
Q, Leader A and Tsang BK. Inhibitory
role of prohibitin and chemerin in FSH-induced rat granulosa cell
steroidogenesis. Endocrinology 154: 956-967 (2013).
Xue
K, Liu JY, Murphy BR and Tsang BK.
Orphan nuclear receptor NR4A1 is a negative regulator of DHT-induced rat
preantral follicular growth. Molecular Endocrinology 26: 2004-2015 (2012)
All Other Publications
Wang PW, Abedini MR, Yang LX, Ding AA, Figeys D, Chang JY, Tsang BK, Shieh DB. Gelsolin regulates cisplatin sensitivity in human head-and-neck cancer.
Int J Cancer. 2014 Apr 26. doi: 10.1002/ijc.28928. [Epub ahead of
print]
Farrand
L, Kim JY, Byun S, Im-Aram A, Lee JH, Lee KW, Suh JY, Lee
HJ and Tsang BK. Hirsutenone sensitizes chemoresistant ovarian
cancer cells to cisplatin via modulation of apoptosis inducing factor and
X-linked inhibitor of apoptosis protein. J Biol Chem 2014 Jan 17;289(3):1723-31.
Xue K, Kim JY, Liu JY, and Tsang BK Insulin-like 3-induced Rat
Preantral Follicular Growth is mediated by Growth Differentiation Factor 9.
Endocrinology 2014
Jan;155(1):156-67.
Im-aram
A, Farrand L, Bae SM, Song GH, Song YS, Han
JY, and Tsang BK. The mTORC2 component Rictor confers cisplatin resistance in human ovarian
cancer cells. PLOS ONE 8(9): e75455. doi:10.1371 (2013)
Farrand
L, Kim JY, Im-Aram A, Suh JY, Lee HJ and Tsang BK. An improved quantitative approach for the assessment of
mitochondrial fragmentation in chemoresistant ovarian cancer cells. PLOS ONE
8(9): e74008. doi:10.1371 (2013)
Orisaka M, Hattori K, Fukuda S, Mizutani T,
Miyamoto K, Tsang BK, Kotsuji F and
Yoshida Y. Dysregulation of ovarian follicular development: LH decreases FSH sensitivity during
preantral-early antral transition. Endocrinology 154: 2870-2880 (2013).
Hossain
M, Cao M, Wang Q, Kim JY, Schellander K, Tesfaye D, and Tsang BK. Altered
expression of miRNAs in a dihydrotestosterone-induced rat PCOS model. J Ovarian
Research 6: 36 (2013)
Wang Q, Leader A and Tsang
BK. Fullicular
stage-dependent regulation of apoptosis and steroidogenesis by prohibibitin in
rat granulose cells. J Ovarian Research 6:23 (2013).
Han YY, Xia GL and Tsang BK. Regulation of
Cyclin D2 Expression and Degradation by Follicle Stimulating Hormone during Rat
Granulosa Cell Proliferation in vitro. Biol Reprod. 2013 Mar 7;88(3):57.
Kobayashi
N, Abedini MR, Sakuragi N and Tsang
BK. PRIMA-1 increases cisplatin sensitivity in chemoresistant ovarian
cancer cells with p53 mutation: a requirement for Akt down-regulation. J
Ovarian Research 2013 Jan 26;6:7.
Du MR, Qiu Q, Gruslin A, Gordon J,
Li
DJ and Tsang BK. SB225002 promotes mitotic catastrophe in chemo-sensitive and –resistant
ovarian cancer cells independent of p53 status in vitro. PLOS ONE 2013;8(1):e54572.
Wang Q, Leader A and Tsang BK. Inhibitory role of chemerin and prohibitin on
FSH-induced steroidogenesis. Endocrinology 154: 956-967 (2012).
Ali AY, Farrand L, Kim JY, Byun
S, Suh JY, Lee HJ and Tsang BK.
Molecular determinants of ovarian cancer chemoresistance: new insights into an
old conundrum. Ann NY Acad Sci 1271: 58-67 (2012)
Wang Q, Kim JY, Xue K, Liu JY, Leader A and Tsang BK. Chemerin, a novel
regulator of follicular growth and steroidogenesis and its potential
involvement in the pathogenesis of PCOS. Endocrinology 153: 5600-5611 (2012).
Woo MG, Xue K, Liu JY, McBribe H. and Tsang BK.
Calpain-mediated processing of p53-associated,
Parkin-like cytoplasmic protein (PARC) affects chemosensitivity of human
ovarian cancer cells by promoting p53 subcellular trafficking. J Biol. Chem. 287: 3963–3975 (2012)
Ali AY, Abedini
MR, Tsang BK. The oncogenic phosphatase
PPM1D confers cisplatin resistance in ovarian carcinoma cells by attenuating
checkpoint kinase 1 and p53 activation.
Oncogene 2011: 2175-2186 (2012)
Zhang C, Xia G, Tsang BK. Interaction of thyroid hormone and FSH in the
regulation of rat granulose cell apoptosis.
Frontiers Biosci (Elite Ed.) Jun 1; 3:1401-1413 (2011).
Al-Bahlani S,
Fraser M, Wong AY, Sayan BS, Bergeron R, Melino G, Tsang BK. P73 regulates
cisplatin-induced apoptosis in ovarian cancer cells via a
calcium/calpain-dependent mechanism.
Oncogene Oct 13;30(41):4219-4230 (2011).
Haider M, Qiu Q,
Bani-Yaghoub M, Tsang BK, Gruslin A.
Characterization and role of NUMB in the human extravillous
trophopblast. Placenta Jun;32(6):441-449
(2011).
Leung EL, Wong JC,
Johlfs MG, Tsang BK, Fiscus RR. Protein kinase G type 1alpha activity in human
ovarian cancer cells significantly contributes to enhanced Src activation and
DNA synthesis/cell proliferation. Mol Cancer Res. 8(4): 578-591 (2010).
Jiang JY, Xiong
HL, Cao MJ, Xia XH, Sirard M-A, Tsang BK
Granulosa cell gene expression associated with oocyte
developmental competence. J Ovarian Research 3:6, 2010.
Fu JJ, Lv XY, Lin HY, Wu L, Wang R, Zhou Z, Zhang BH, Tsang BK, Zhu C, Wang HM. Ubiquitin ligase cullin 7 induces
epithelial-mesenchymal transition in human choriocarcinoma cells. J Biol. Chem. 285(14): 10870-10879 2010.
Abedini MR,
Muller EJ, Bergeron R, Gray DA, Tsang BK.
Akt promotes chemoresistance in
human ovarian cancer cells by modulating cisplatin-induced, p53-dependent
ubiquitination of FLICE-like inhibitory protein. Oncogene 29: 11-25 (2010).
Leung EL, Wong JC, Johlfs MG, Tsang BK and Fiscus RR. Protein kinase
G type 1alpha activity in human ovarian cancer cells significantly contributes
to enhanced Src activation and DNA synthesis/cell proliferation. Mol. Can. Res.
8(4): 578-591 (2010)
Qiu Q, Yan XY, Bell M, Di JM, Tsang BK and Gruslin A. Mature IGF-II
prevents the formation of “big” IGF-II/IGFBP-2 complex in the human
circulation. Growth Horm. IGF Res. 2010 Apr;20(2): 110-117.
Kobayashi N, Orisaka M, Cao MJ, Kotsuji F,
Leader A, Sakuragi N, and Tsang, BK.
Growth differentiation factor-9 mediates the interaction between FSH and
thyroid hormone in the regulation of rat preantral
follicular development. Endocrinology 150: 5566-5574(2009).
Orisaka M, Jiang J-Y, Orisaka S, Kotsuji F
and Tsang BK. Growth Differentiation
Factor-9 promotes preantral follicle development through up-regulation of
androgen production. Endocrinology 150: 2740-2748 (2009).
Fu JJ, Lin P, Lv XY, Yan XJ, Wang HX, Zhu C, Tsang BK, Yu XG and Wang HM. Low
molecular mass polypeptide-2 in
human extravillous trophoblast: over-expression in hydatidiform mole and
possible role in trophoblast cell invasion.
Placenta 30(4):305-312 (2009).
Orimoto AM, Dumaresq-Doiron K, Jiang JY,
Tanphaichitr N, Tsang BK and Carmona
E. Mammalian hyaluronidase induces ovarian granulosa cell apoptosis and is
involved in the induction of follicular atresia. Endocrinology 150:5566-5574
(2009).
Abedini MR, Muller
EJ, Brun J, Bergeron R, Gray DA and Tsang BK. Cisplatin induces
p53-dependent FLICE-like inhibitory protein (FLIP) ubiquitination in ovarian
cancer cells. Cancer Research 68: 4511-4517 (2008).
Leung LH, Fraser M, Fiscus RR and Tsang BK. Cisplatin alters nitric oxide synthase levels in human
ovarian cancer cells: involvement in p53 regulation and cisplatin resistance. Br. J. Cancer 98,
1803-1809 (2008).
Gregory-Bass RC, Olatinwo M , Xu W, Matthews R, Stiles JK, Thomas K, Liu D, Tsang BK and Thompson WE. Prohibitin silencing reverses
stabilization of mitochondrial integrity and chemoresistance in ovarian cancer
cells by increasing their sensitivity to apoptosis. Internat. J. Cancer 122:
1923-1930 (2008).
Yang X, Fraser M, Abedini MR, Bai T and Tsang BK. Regulation of AIF-Mediated,
Cisplatin-Induced Apoptosis by Akt. Br. J. Cancer 98: 803-808 (2008).
Fraser M, Bai T
and Tsang BK. Akt promotes cisplatin resistance in human
ovarian cancer cells through inhibition of p53 phosphorylation and nuclear
function. Internat. J Cancer. 122:534-546
(2008).
Wang HM and Tsang
BK. Nodal signaling and Apoptosis. Reproduction 133: 1-8 (2007).
Craig J, Orisaka M, Wang HM, Orisaka S,
Thompson W, Zhu C, Kotsuji F and Tsang
BK. Gonadotropin and intra-ovarian signals regulating follicle development
and atresia: the delicate balance between life and death. Frontiers in
Bioscience 12: 3628-3639 (2007).
Bissonette
F, Cohen J, Collins J, Cowan L, Dales S, Dills S, Greene C, Gysler M, Hanck B,
Hughes E, Leader A, McDonald S, Marrin M, Martin R, Min J, Mortimer D, Mortimer
S, Smith J, Tsang BK, Van Vugt D and
Yuzpe A (in alphabetical order). Incidence and complications of multiple
gestation in Canada: proceedings of an expert meeting. Reproductive BioMedicine Online. Vol 14, No 6, 773-790 (2007).
Qiu Q, Jiang JY, Bell M, Tsang BK and Gruslin A. Activation of endoproteolytic processing of
IGF-II in fetal, early postnatal and pregnant rats and persistence of
circulating levels in postnatal life. Endocrinology 148: 4803- 4811 (2007).
Jahani-Asl A, Basak
A and Tsang BK. Caspase-3-mediated cleavage of Akt: involvement of
non-consensus sites and influence of phosphorylation. FEBB Letters. 581:
2883-2888 (2007).
Wu A,
Anupriwan A, Iamsaard S, Chakrabandhu K, Santos DC, Rupar T, Tsang
BK, Carmona E and Tanphaichitr N. Sperm Surface Arylsulfatase A Can Disperse the Cumulus Matrix of
Cumulus Oocyte Complexes. J. Cell Physiol. 213: 201-211 (2007).Listings from The Ottawa Hospital Library
This lists the 24 most recent publications in The Ottawa Hospital's Library database from this lab.This database only starts tracking a researcher's publications once they start working at the Ottawa Hospital Research Institute.
PubMed Listings